Merck & Co Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (117)

Latest Posts

About This Stock More About This Stock
Merck Rises, Bristol-Myers Slides Following Cancer Meeting
Article By: The Fly
Monday, April 16, 2018 11:09 AM EDT
Shares of Merck are rising this morning, while peer Bristol-Myers is sliding, after both companies presented new data on their respective cancer immunotherapy treatments at the American Association for Cancer Research annual meeting.
In this article: BMY, MRK
The 8 'Dogs Of The Dow' Hit Hard In First Quarter, Here's How To Trade Them Now
Article By: Richard Suttmeier
Sunday, April 8, 2018 8:00 AM EDT
The eight "Dogs of the Dow" for 2018 ended March with an aggregate loss of 7.5% year-to-date.
In this article: CVX, IBM, KO, MRK, PFE, PG, VZ, XOM
NewLink Genetics Plunges After Competitor IDO Drug Fails In Trial
Article By: The Fly
Friday, April 6, 2018 1:08 PM EDT
Shares of NewLink Genetics (NLNK), a clinical-stage company focused on cancer, plunged in pre-market trading after a competitor exploring the same areas of cancer treatment reported a clinical trial that did not succeed in achieving its goal.
In this article: MRK, NLNK, NKTR
2018 Dogs Of The Dow
Article By: Gavin McMaster
Wednesday, March 21, 2018 4:15 AM EDT
The Dogs of the Dow theory was created in 1972 and has proven to be successful more often than not over the years. Sometimes the simple things work the best and this strategy is simplicity to the core.
In this article: GE, IBM, MRK, VZ, XOM
Merck (MRK) Beats On Q4 Earnings, Lags Sales, Guides For '18
Article By: Zacks Investment Research
Friday, February 2, 2018 11:45 AM EDT
Merck & Co., Inc. reported fourth-quarter 2017 adjusted earnings of 98 cents per share, which beat the Zacks Consensus Estimate of 94 cents by 4.3%. Earnings rose 10.1% year over year.
In this article: MRK Also: GSK, JNJ, SNY


Latest Tweets for $MRK

No tweets yet!


OncoSec Raising Its Profile In Fight Against Cancer
Harry Goldstein 9/7/2017 5:43:14 PM

I appreciate a promising investment that also helps people. Bullish on $ONCS and $MRK.

OncoSec Raising Its Profile In Fight Against Cancer
Alexis Renault 9/6/2017 4:08:15 PM

Thanks for this info, Terry Chrisomalis. Is there any sort of official partnership or cooperation between #OncoSecMedical and #Merck to use ImmunoPulse IL-12 technology in conjunction with #Keytruda? $ONCS $MRK

OncoSec Raising Its Profile In Fight Against Cancer
Dick Kaplan 9/6/2017 4:03:09 PM

Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY

1 to 3 of 3 comments